Based on its recent analysis of the hip replacement market, Frost & Sullivan recognizes Intellijoint Surgical with the 2015 North American Frost & Sullivan Award for Enabling Technology Leadership. Intellijoint Surgical’s flagship product, intellijoint HIP™, can greatly increase the success rates of hip replacement procedures by providing orthopedic surgeons with real-time data measurements of cup position, leg length, and offset intraoperatively. Accurate implant selection and alignment improves patients’ outcomes and reduces overall treatment costs.
“intellijoint HIP™, incorporates Intellijoint Surgical’s proprietary core technology, a miniaturized 3D surgical measurement system placed within the sterile field that provides surgeons with accurate measurements in real-time,” said Frost & Sullivan Best Practices Director, Tonya Fowler. “The data assists surgeons in selecting the best-fitting implant for the patient and helps align the implant in the desired location that is critical for a successful surgical outcome.”
Orthopedic surgeons are equipped with preoperative images of the patient’s hip, but these images are only useful in helping the surgeon create a preoperative plan, not execute it. intellijoint HIP™ provides surgeons with 3D information intraoperatively, helping them with proper implant selection, positioning, and alignment that ultimately improves accuracy in achieving preoperative targets.
Aided by intellijoint HIP™, orthopedic surgeons no longer have to ‘eye ball’ or manually position hip implants, as the device enhances placement precision and minimizes the risk of joint instability, which can lead to additional negative consequences for the patient such as dislocation and leg length discrepancy. intellijoint HIP is safe, fast, accurate and seamlessly integrates with surgeons’ workflows. It is affordable and does not impact operating room time. Additionally, intellijoint HIP™ gives surgeons greater confidence to recommend hip replacement surgery, as the risk for revision hip surgery may be lowered.
Intellijoint Surgical is aware of the huge capital expenses hospitals incur in surgical procedures and, as such, the company does not demand a large upfront capital investment for intellijoint HIP™. Intellijoint Surgical has a pay-per-use model, with manageable fees that do not require C-level executive approvals. The approvals can be obtained fromthe Operating Room Manager.
“Intellijoint Surgical has demonstrated the long-term viability and impact of its core technology through its innovative new product in hip replacement. It is a great pleasure to recognize Intellijoint Surgical for developing a technology that allows all orthopedic surgeons to benefit from computer-assisted surgery and deliver improved outcomes for their patients,” said Krishna Srinivasan, global president and managing partner, Frost & Sullivan.
For its utility in enhancing the efficiency of orthopedic surgeries and reducing hospital costs, Frost & Sullivan is pleased to present Intellijoint Surgical with the 2015 North American Frost & Sullivan Award for Enabling Technology Leadership.
Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products but also enables the development of newer products and applications. The award recognizes the high market acceptance potential of the recipient’s technology.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About Intellijoint Surgical
Intellijoint Surgical is a Waterloo-based innovative medical technology company. Founded in 2010, they develop and commercialize miniaturized surgical smart tools that enhance surgeon accuracy, increase hospital economic efficiencies, and improve patient outcomes. The company’s R&D team is led by the former co-founder of Medtronic’s computer assisted surgery division, and driven by a team of renowned orthopedic surgeons: Drs. Allan Gross and David Backstein in Toronto, Dr. Wayne Paprosky in Chicago, Dr. Javad Parvizi in Philadelphia and Drs. Michael Cross and Ran Schwarzkopf in New York.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation